Posts by: jgrossmn

Innovator of the Year Tackles Type 1 Diabetes

  Two million people in the US live with potentially deadly type 1 diabetes, and Ed Damiano wants to make them healthier, safer, and “dramatically unburdened from managing their diabetes.” Among those people is his son. Damiano was honored on July 12 as Boston University’s 2016 Innovator of the Year for his efforts developing an […]

Klogene Therapeutics, Inc. awarded a $1.49 Million grant for Alzheimers disease drug development

  BOSTON, MA – 16 May, 2016 – Klogene Therapeutics, Inc. today announced that it has been awarded a $1.49 Million small business innovation research grant (SBIR) by the National Institute on Aging (NIA) of the National Institutes of Health (NIH). The funds from this award (number R44AG053084) will be used for the development of novel […]

Hope for the Battle against Type 1 Diabetes

Ed Damiano (center) and members of new medical device company Beta Bionics, whose mission is to improve the health of people with type 1 diabetes: (from left) design engineers Raj Setty and Rob LeBourdais; senior engineer Firas El-Khatib; Ed Raskin, VP for public benefit development and corporate strategy; Serafina Raskin, VP and general counsel; and […]

Beta Bionics Raises $5 Million

The race is on for what may be the biggest innovation in decades for Type 1 diabetes management—the bionic pancreas—and on Friday, one of the lead researchers in the field announced at the Endocrine Society’s annual meeting that he’s launched a company to bring that invention to market. Ed Damiano, a professor of biomedical engineering at […]